D. E. Shaw & Co., Inc. Surmodics Inc Transaction History

D. E. Shaw & Co., Inc.

$122 Billion
Q4 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Surmodics Inc stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 125,927 shares of SRDX stock, worth $4.29 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

125,927

Previous 89,498 40.7%

Holding current value

$4.29 Million

Previous $3.47 Million 43.69%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$37.5 - $40.13 $1.37 Million - $1.46 Million	36,429 Added 40.7%	125,927 $4.99 Million
Q3 2024 Nov 14, 2024	BUY	$38.47 - $42.24 $1.2 Million - $1.32 Million	31,142 Added 53.37%	89,498 $3.47 Million
Q2 2024 Aug 14, 2024	BUY	$25.39 - $42.1 $27,929 - $46,310	1,100 Added 1.92%	58,356 $2.45 Million
Q1 2024 May 15, 2024	BUY	$27.44 - $35.56 $190,927 - $247,426	6,958 Added 13.83%	57,256 $1.68 Million
Q4 2023 Feb 14, 2024	SELL	$28.47 - $38.49 $5,523 - $7,467	-194 Reduced 0.38%	50,298 $1.83 Million
Q3 2023 Nov 14, 2023	SELL	$28.28 - $38.36 $838,982 - $1.14 Million	-29,667 Reduced 37.01%	50,492 $1.62 Million
Q2 2023 Aug 14, 2023	SELL	$17.67 - $31.31 $327,796 - $580,831	-18,551 Reduced 18.79%	80,159 $2.51 Million
Q1 2023 May 15, 2023	BUY	$17.13 - $38.52 $1.38 Million - $3.09 Million	80,281 Added 435.62%	98,710 $2.25 Million
Q4 2022 Feb 14, 2023	BUY	$29.44 - $37.31 $115,964 - $146,964	3,939 Added 27.18%	18,429 $628,000
Q3 2022 Nov 14, 2022	SELL	$28.84 - $38.92 $15,631 - $21,094	-542 Reduced 3.61%	14,490 $440,000
Q2 2022 Aug 15, 2022	BUY	$33.25 - $45.11 $26,965 - $36,584	811 Added 5.7%	15,032 $560,000
Q1 2022 May 16, 2022	SELL	$40.68 - $49.72 $65,454 - $79,999	-1,609 Reduced 10.16%	14,221 $645,000
Q4 2021 Feb 14, 2022	SELL	$43.21 - $57.6 $355,704 - $474,163	-8,232 Reduced 34.21%	15,830 $762,000
Q3 2021 Nov 15, 2021	SELL	$52.8 - $60.32 $494,841 - $565,319	-9,372 Reduced 28.03%	24,062 $1.34 Million
Q2 2021 Aug 16, 2021	SELL	$51.29 - $59.15 $207,519 - $239,320	-4,046 Reduced 10.8%	33,434 $1.81 Million
Q1 2021 May 17, 2021	SELL	$42.18 - $56.07 $166,442 - $221,252	-3,946 Reduced 9.53%	37,480 $2.1 Million
Q4 2020 Feb 16, 2021	SELL	$35.18 - $43.52 $101,248 - $125,250	-2,878 Reduced 6.5%	41,426 $1.8 Million
Q3 2020 Nov 16, 2020	SELL	$37.98 - $48.72 $373,495 - $479,112	-9,834 Reduced 18.16%	44,304 $1.72 Million
Q2 2020 Aug 14, 2020	SELL	$31.07 - $44.74 $328,844 - $473,528	-10,584 Reduced 16.35%	54,138 $2.34 Million
Q1 2020 May 15, 2020	BUY	$22.46 - $42.24 $877,938 - $1.65 Million	39,089 Added 152.49%	64,722 $2.16 Million
Q4 2019 Feb 14, 2020	SELL	$39.01 - $47.51 $464,765 - $566,034	-11,914 Reduced 31.73%	25,633 $1.06 Million
Q3 2019 Nov 14, 2019	SELL	$38.66 - $47.41 $2.84 Million - $3.48 Million	-73,349 Reduced 66.14%	37,547 $1.72 Million
Q2 2019 Aug 14, 2019	BUY	$38.23 - $47.43 $1.17 Million - $1.45 Million	30,546 Added 38.02%	110,896 $4.79 Million
Q1 2019 May 15, 2019	BUY	$41.26 - $58.35 $46,871 - $66,285	1,136 Added 1.43%	80,350 $3.49 Million
Q4 2018 Feb 14, 2019	BUY	$44.93 - $73.38 $1.15 Million - $1.88 Million	25,581 Added 47.7%	79,214 $3.74 Million
Q3 2018 Nov 14, 2018	SELL	$56.85 - $80.35 $749,680 - $1.06 Million	-13,187 Reduced 19.74%	53,633 $4 Million
Q2 2018 Aug 14, 2018	SELL	$35.85 - $57.05 $799,813 - $1.27 Million	-22,310 Reduced 25.03%	66,820 $3.69 Million
Q1 2018 May 15, 2018	BUY	$27.0 - $38.5 $15,903 - $22,676	589 Added 0.67%	89,130 $3.39 Million
Q4 2017 Feb 14, 2018	SELL	$28.0 - $33.2 $109,900 - $130,310	-3,925 Reduced 4.24%	88,541 $2.48 Million
Q3 2017 Nov 14, 2017	BUY	$24.5 - $31.1 $2.27 Million - $2.88 Million	92,466	92,466 $2.87 Million

Others Institutions Holding SRDX

# of Institutions

141

Shares Held

12M

Call Options Held

31.4K

Put Options Held

13.2K

View Full List

About SURMODICS INC

Ticker SRDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,005,000
Market Cap $478M
Description
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...

More about SRDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account